Ethics statement
The study was approved by the UK Health Research Authority Research Ethics Committee South Central—Oxford A (16/SC/0147. The trial was registered at ClinicalTrials.gov (NCT02653209) and the ISRCTN registry (12039221).The primary analysis of the trial, as detailed in the study protocol